Patents by Inventor Stefano Bongrani

Stefano Bongrani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-Aminotetralin derivatives for the therapy of glaucoma
    Patent number: 6953813
    Abstract: The use of racemic or optically active compounds represented by formula (I) and the salts thereof wherein R is H or CH3 for the preparation of pharmaceutical compositions for the therapy of ophthalmic disorders.
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: October 11, 2005
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Stefano Bongrani, Roberta Razzetti, Paolo Chiesi
  • Aminotetralin derivative for the therapy of cardiovascular diseases
    Publication number: 20030207944
    Abstract: Left ventricular dysfunction is treated by a process, comprising: administering to a subject suffering from left ventricular remodeling a therapeutically effective amount of 5,6-dihydroxy-2-methylaminotetralin, or 5,6-diisobutyroyl-oxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof in combination with an angiotensin-converting enzyme inhibitor.
    Type: Application
    Filed: April 11, 2003
    Publication date: November 6, 2003
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Stefano Bongrani, Roberta Razzetti, Maurizio Civelli, Alberto Umile, Paolo Chiesi
  • Aminotetralin derivatives for the therapy of cardiovascular diseases
    Patent number: 6576671
    Abstract: The invention relates to a method of treatment of left ventricular dysfunction, by administering to a subject suffering from left ventricular remodeling a therapeutically effective amount of 5,6-dihydroxy-2-methylaminotetralin or 5,6-diisobutyroyl-oxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 19, 2002
    Date of Patent: June 10, 2003
    Assignee: Chiese Farmaceutici S.p.A.
    Inventors: Stefano Bongrani, Roberta Razzetti, Maurizio Civelli, Alberto Umile, Paolo Chiesi
  • Aminotetralin derivative for the therapy of cardiovascular diseases
    Patent number: 6103760
    Abstract: Left ventricular dysfunction is treated by a process, comprising:administering to a subject suffering from left ventricular remodeling a therapeutically effective amount of 5,6-dihydroxy-2-methylaminotetralin, or 5,6-diisobutyroyl-oxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof in combination with an angiotensin-converting enzyme inhibitor.
    Type: Grant
    Filed: June 9, 1999
    Date of Patent: August 15, 2000
    Assignee: Chiesi Farmaceuticals S.p.A.
    Inventors: Paolo Chiesi, Stefano Bongrani, Roberta Razzetti, Maurizio Civelli, Alberto Umile
  • Aminotetralin derivative for the therapy of cardiovascular diseases
    Patent number: 6013678
    Abstract: A method of treating congestive heart failure is diclosed comprising administering 5,6-dihydroxy- or 5,6-diisobutyroyloxy-2-methylaminotetralin or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: January 11, 2000
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Paolo Chiesi, Stefano Bongrani, Roberta Razzetti, Maurizio Civelli, Alberto Umile
  • 2-amino-1,2,3,4-tetrahydronaphthalene derivatives with cardiovascular activity, process for their preparation and pharmaceutical compositions containing them
    Patent number: 5096929
    Abstract: 5,6-Dimethoxy-2-[2-(4-hydroxyphenyl)-2-hydroxy-2-methylethyl]amino- 1,2,3,4-tetrahydronaphthalene has inotropic and vasodilating activities and therefore can be used in the treatment of cardiocirculatory failure. The compound can be in the form of a single stereoisomer or as a mixture of two or more stereoisomers.
    Type: Grant
    Filed: June 26, 1990
    Date of Patent: March 17, 1992
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Paolo Chiesi, Stefano Bongrani, Maurizio Delcanale, Vittorino Servadio